These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2859117)

  • 1. Treatment of irritable bowel syndrome with prifinium bromide.
    Sasaki D; Suzuki A; Yoshida Y; Okamoto K; Ohmi T; Takahashi S; Yoshida S; Fukushi K; Higuchi K
    Clin Ther; 1985; 7(2):190-8. PubMed ID: 2859117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of prifinium bromide therapy in irritable bowel syndrome.
    Sasaki T; Takekoshi T; Okada T
    Clin Ther; 1985; 7(4):512-21. PubMed ID: 2861900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prifinium bromide in the treatment of the irritable colon syndrome.
    Piai G; Mazzacca G
    Gastroenterology; 1979 Sep; 77(3):500-2. PubMed ID: 37142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Action of prifinium bromide on the irritable colon].
    Meduri B; Albano O
    Minerva Dietol Gastroenterol; 1981; 27(1):17-9. PubMed ID: 6114463
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind study of a new antimuscarinic, cimetropium bromide, in patients with irritable bowel syndrome.
    Ferrari A; Cavallero M; Spandre M; Gemme C; Rossini FP; Imbimbo BP
    Clin Ther; 1986; 8(3):320-8. PubMed ID: 3521859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome.
    Centonze V; Imbimbo BP; Campanozzi F; Attolini E; Daniotti S; Albano O
    Am J Gastroenterol; 1988 Nov; 83(11):1262-6. PubMed ID: 3055943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of pinaverium bromide in south Indian patients with irritable bowel syndrome.
    Jayanthi V; Malathi S; Ramathilakam B; Dinakaran N; Balasubramanian V; Mathew S
    J Assoc Physicians India; 1998 Apr; 46(4):369-71. PubMed ID: 11273320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled clinical study on the efficacy of tiropramide hydrochloride in the treatment of irritable colon: comparison with octylonium bromide].
    Tinozzi S; Valesi MG
    Minerva Med; 1984 Jan; 75(1-2):23-31. PubMed ID: 6363985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of pinaverium bromide therapy on colonic motility disorders in irritable bowel syndrome].
    Wittmann T; Fehér A; Rosztóczy A; Jánosi J
    Orv Hetil; 1999 Feb; 140(9):469-73. PubMed ID: 10204402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome.
    Delvaux M; Beck A; Jacob J; Bouzamondo H; Weber FT; Frexinos J
    Aliment Pharmacol Ther; 2004 Jul; 20(2):237-46. PubMed ID: 15233705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of irritable bowel syndrome. Two doses of mebeverine compared.
    Prout BJ
    Practitioner; 1983 Oct; 227(1384):1607-8. PubMed ID: 6356119
    [No Abstract]   [Full Text] [Related]  

  • 12. Double blind trial of trimebutine in the irritable bowel syndrome.
    Fielding JF
    Ir Med J; 1980 Oct; 73(10):377-9. PubMed ID: 7000730
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical use of prifinium bromide: a new spasmolytic agent].
    Marini U; Spotti D; Visconti P
    Clin Ter; 1978 Nov; 87(4):367-74. PubMed ID: 36254
    [No Abstract]   [Full Text] [Related]  

  • 14. [The otilonium bromide-benzodiazepine combination in the therapy of the irritable colon syndrome].
    Capurso L; Del Sette F; Ferrario F; Tarquini M
    Clin Ter; 1992 Aug; 141(8):121-7. PubMed ID: 1395454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of irritable bowel syndrome: results of a randomized controlled trial.
    Misra SP; Thorat VK; Sachdev GK; Anand BS
    Q J Med; 1989 Oct; 73(270):931-9. PubMed ID: 2697886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diltiazem in the treatment of the irritable bowel syndrome.
    Pérez-Mateo M; Sillero C; Cuesta A; Vazquez N; Berbegal J
    Int J Clin Pharmacol Res; 1986; 6(5):425-7. PubMed ID: 3781705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double blind trial of ispaghula/poloxamer in the Irritable Bowel Syndrome.
    Arthurs Y; Fielding JF
    Ir Med J; 1983 May; 76(5):253. PubMed ID: 6307924
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of withdrawing tegaserod treatment in comparison with continuous treatment in irritable bowel syndrome patients with abdominal pain/discomfort, bloating and constipation: a clinical study.
    Bardhan KD; Forbes A; Marsden CL; Mason T; Short G
    Aliment Pharmacol Ther; 2004 Jul; 20(2):213-22. PubMed ID: 15233702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome.
    Mangel AW; Bornstein JD; Hamm LR; Buda J; Wang J; Irish W; Urso D
    Aliment Pharmacol Ther; 2008 Jul; 28(2):239-49. PubMed ID: 18466359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The irritable colon syndrome. New therapeutic possibilities in the treatment of a frequent syndrome].
    Eisenburg J; Kruis W; Schüssler P; Weinzierl M
    Fortschr Med; 1978 Nov; 96(41):2064-70. PubMed ID: 700592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.